Maynard Um
-
-
-
-
-
-
-
Prosensa Holding N.V. (RNA) Misses Q3 EPS by 13c
-
-
-
-
-
-
-
Citi Downgrades Avidity Biosciences (RNA) to Neutral
-
-
-
-
-
-
-
Novartis Said To Near Deal $70-per-share-plus Deal For Avidity Biosciences (RNA) - Bloomberg
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
-
-
-
-
-
-
-
TD Cowen's Best Smidcap Ideas 2025
-
-
-
-
-
-
-
Avidity Biosciences (RNA) Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran
-
-
-
-
-
-
-
BMO Capital Starts Avidity Biosciences (RNA) at Outperform (correction)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

